Product Images Cyclobenzaprine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Cyclobenzaprine Hydrochloride NDC 53002-3080 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01
IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02
This is a description of the side effects of Cyclobenzaprine HCI tablets at 5mg and 10mg doses, as compared to a placebo. The side effects that were observed and their percentages are listed, including drowsiness, dry mouth, fatigue, and headache. The data is broken down by dosage and compared to the placebo.*
IMAGE - 7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03
This text appears to be a report on clinical studies and a surveillance program conducted with Cyclobenzaprine HCl tablets. The studies and program reveal the following percentages of side effects: drowsiness at 39%, dry mouth at 2%, and dizziness at 1%. The surveillance program showed a 16% rate of adverse reactions and a 7% incidence of drowsiness, and 3% incidence of dry mouth.*
Label Image - lbl530023080
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.